XPR1 and ovarian cancer: Second, XPR1 down-regulation used gene silencing technology, and did not use gene editing technology; third, the animal experiment used nude mouse subcutaneous tumor formation technology and did not use ovarian cancer in situ tumor technology, which cannot reflect the abdominal metastasis process of ovarian cancer.